Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Change in Inventory: 2024-2025

Historic Change in Inventory for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Sep 2025 value amounting to -$1.2 million.

  • Tonix Pharmaceuticals Holding's Change in Inventory rose 2.17% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 million, marking a year-over-year change of. This contributed to the annual value of -$3.7 million for FY2024, which is 6032.79% down from last year.
  • Per Tonix Pharmaceuticals Holding's latest filing, its Change in Inventory stood at -$1.2 million for Q3 2025, which was down 1,038.46% from $130,000 recorded in Q2 2025.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Change in Inventory registered a high of $130,000 during Q2 2025, and its lowest value of -$1.3 million during Q1 2024.
  • In the last 2 years, Tonix Pharmaceuticals Holding's Change in Inventory had a median value of -$1.2 million in 2024 and averaged -$729,000.
  • Data for Tonix Pharmaceuticals Holding's Change in Inventory shows a peak YoY spiked of 111.25% (in 2025) over the last 5 years.
  • Over the past 2 years, Tonix Pharmaceuticals Holding's Change in Inventory (Quarterly) stood at -$50,000 in 2024, then climbed by 2.17% to -$1.2 million in 2025.
  • Its Change in Inventory was -$1.2 million in Q3 2025, compared to $130,000 in Q2 2025 and -$272,000 in Q1 2025.